Inhibition of mTORC1 signaling sensitizes hepatocellular carcinoma cells to glycolytic stress

American Journal of Cancer Research

Volumn 6, Issue 10, 2016, Pages 2289-2298

  Zhao, Xin ^a   Jiang, Peng ^a   Deng, Xiang ^a   Li, Zhonghu ^a   Tian, Feng ^a   Guo, Fei ^a   Li, Xiaowu ^a   Wang, Shuguang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Glycolysis; Hepatocellular carcinoma; Lactate dehydrogenase a; MTOR signaling

Indexed keywords

DEOXYGLUCOSE; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE A; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MYC PROTEIN; RAPAMYCIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CELL LYSATE; CONTROLLED STUDY; CYTOTOXICITY; GENE SILENCING; GENE TARGETING; GLYCOLYSIS; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84995549384     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108
2. Xu X, Lu D, Ling Q, Wei X, Wu J, Zhou L, Yan S, Wu L, Geng L, Ke Q, Gao F, Tu Z, Wang W, Zhang M, Shen Y, Xie H, Jiang W, Wang H and Zheng S. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria. Gut 2016; 65: 1035-1041
3. Zhong JH, Ke Y, Wang YY and Li LQ. Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension. Gut 2015; 64: 520-521
4. Stotz M, Gerger A, Haybaeck J, Kiesslich T, Bullock MD and Pichler M. Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future. Anticancer Res 2015; 35: 5737-5744
5. Hanahan D and Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674
6. Liberti MV and Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci 2016; 41: 211-218
7. Zhang D, Li J, Wang F, Hu J, Wang S and Sun Y. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy. Cancer Lett 2014; 355: 176-183
8. Dwarakanath B and Jain V. Targeting glucose metabolism with 2-deoxy-D-glucose for improving cancer therapy. Future Oncol 2009; 5: 581-585
9. Talekar M, Boreddy SR, Singh A and Amiji M. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery. Expert Opin Biol Ther 2014; 14: 1145-1159
10. Kurtoglu M, Maher JC and Lampidis TJ. Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells. Antioxid Redox Signal 2007; 9: 1383-1390
11. Kurtoglu M, Gao N, Shang J, Maher JC, Lehrman MA, Wangpaichitr M, Savaraj N, Lane AN and Lampidis TJ. Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation. Mol Cancer Ther 2007; 6: 3049-3058
12. Wahlstrom T and Henriksson MA. Impact of MYC in regulation of tumor cell metabolism. Biochim Biophys Acta 2015; 1849: 563-569
13. Schmidt EV, Ravitz MJ, Chen L and Lynch M. Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway. Cell Cycle 2009; 8: 1344-1351
14. Prasanna VK, Venkataramana NK, Dwara-Kanath BS and Santhosh V. Differential responses of tumors and normal brain to the combined treatment of 2-DG and radiation in glioablastoma. J Cancer Res Ther 2009; 5 Suppl 1: S44-47
15. Sheng SL, Liu JJ, Dai YH, Sun XG, Xiong XP and Huang G. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J 2012; 279: 3898-3910
16. Iansante V, Choy PM, Fung SW, Liu Y, Chai JG, Dyson J, Del Rio A, D'Santos C, Williams R, Chokshi S, Anders RA, Bubici C and Papa S. PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation. Nat Commun 2015; 6: 7882
17. Dai W, Wang F, Lu J, Xia Y, He L, Chen K, Li J, Li S, Liu T, Zheng Y, Wang J, Lu W, Zhou Y, Yin Q, Abudumijiti H, Chen R, Zhang R, Zhou L, Zhou Z, Zhu R, Yang J, Wang C, Zhang H, Zhou Y, Xu L and Guo C. By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice. Oncotarget 2015; 6: 13703-13717
18. Raught B, Gingras AC and Sonenberg N. The target of rapamycin (TOR) proteins. Proc Natl Acad Sci U S A 2001; 98: 7037-7044
19. Choo AY, Kim SG, Vander Heiden MG, Mahoney SJ, Vu H, Yoon SO, Cantley LC and Blenis J. Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol Cell 2010; 38: 487-499
20. Duvel K, Yecies JL, Menon S, Raman P, Lipovsky AI, Souza AL, Triantafellow E, Ma Q, Gorski R, Cleaver S, Vander Heiden MG, MacKeigan JP, Finan PM, Clish CB, Murphy LO and Manning BD. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 2010; 39: 171-183
21. Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB and Thomas G. Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k. EMBO J 1997; 16: 3693-3704
22. Herbert TP, Tee AR and Proud CG. The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites. J Biol Chem 2002; 277: 11591-11596
23. Dang CV, Le A and Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res 2009; 15: 6479-6483
24. Zhang C, Yang L, Geng YD, An FL, Xia YZ, Guo C, Luo JG, Zhang LY, Guo QL and Kong LY. Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells. Oncotarget 2016; 7: 27819-37
25. Barnhart BC, Lam JC, Young RM, Houghton PJ, Keith B and Simon MC. Effects of 4E-BP1 expression on hypoxic cell cycle inhibition and tumor cell proliferation and survival. Cancer Biol Ther 2008; 7: 1441-1449
26. Pusapati RV, Daemen A, Wilson C, Sandoval W, Gao M, Haley B, Baudy AR, Hatzivassiliou G, Evangelista M and Settleman J. mTORC1-Dependent Metabolic Reprogramming Underlies Escape from Glycolysis Addiction in Cancer Cells. Cancer Cell 2016; 29: 548-562